Back to First Eagle Investment Management, LLC First Eagle Investment Management, LLC

BIOBIO
Showing 8 of 13 quarters

Position history for First Eagle Investment Management, LLCFirst Eagle Investment Management, LLC's holdings in BIO-RAD LABORATORIES-A

First Eagle Investment Management, LLC holds 2.6M shares of BIO (BIO-RAD LABORATORIES-A), worth $765.2M as of 2026-Q2. The position was increased (+0.1% shares). BIO represents 1.3% of First Eagle Investment Management, LLC's portfolio.

Current Value

$765.2M

Current Shares

2.6M

Total Value Change

+$526.7M

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.6M
+0.1%
$765.2M1.3%$293.61
50
2026-Q1
Increased
2.6M
+1.3%
$725.5M1.2%$280.19
50
2025-Q4
Increased
2.6M
+2.0%
$778.8M1.4%$304.51
51
2025-Q3
Increased
2.5M
+0.1%
$706.7M1.3%$270.11
50
2025-Q2
Increased
2.5M
+60.7%
$607.5M1.2%$243.98
72
2025-Q1
Increased
1.6M
+119.5%
$381.5M0.8%$243.00
71
2024-Q4
Increased
713,505
+0.1%
$234.4M0.5%$326.34
43
2024-Q3
Increased
713,000
+12.1%
$238.6M0.5%$331.77
41

Other major holders of BIO: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC, Veritas Asset Management LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used